On Demand CE - Cardiovascular Risk Reduction and LDL-C

Evolving Perspectives in Lipid Management 


Learn about LDL-cholesterol, its relationship to CVD, and the role of non-statin therapies in management from clinical lipid specialists. Case study examples include clinical pearls, making the presentation easily applicable to a variety of practice settings.

Credit: 1.0 CE contact hours, 0.5 Pharmacology hours
Cost: Free, available to members only

Take this Course


  • Margo Minissian, PhDc, ACNP-BC, CLS-BC, CNS, AACC, FAHA
  • Robert Giugliano, MD, MSc

Upon completion of this activity, participants will be able to: 
  • Increased awareness of recent evidence further supporting the relationship between lowering LDL-C and ASCVD risk.
  • Implementation of updated, recommended algorithms for LDL-lowering with non-statin therapies to further reduce ASCVD risk.
  • Increased attainment of LDL-C treatment goals in vulnerable patient populations.
  • Greater confidence in utilizing nonstatin therapies that lower LDL-C well below current targets and demonstrate net ASCVD risk-reduction benefit.
Robert Giugliano, MD, MSc
Margo Minissian speaking at PCNA's Annual Symposium
This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). PCNA is accredited by the American Association of Nurse Practitioners (AANP) as an approved provider of Nurse Practitioner continuing education, provider number 030602.